Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof

Patent No. EP2759294 (titled "Percutaneously Absorbable Preparation Containing Fentanyl And A Homologue Thereof") was filed by Samyang Biopharmaceuticals on Sep 21, 2012. The application was issued on Nov 1, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HEXALJul 31, 2018TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2759294

SAMYANG BIOPHARMACEUTICALS
Application Number
EP12833553A
Filing Date
Sep 21, 2012
Status
Revoked
Mar 20, 2020
Publication Date
Nov 1, 2017